<SEC-DOCUMENT>0001214659-18-000585-index.html : 20180122
<SEC-HEADER>0001214659-18-000585.hdr.sgml : 20180122
<ACCEPTANCE-DATETIME>20180122180029
ACCESSION NUMBER:		0001214659-18-000585
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20180118
FILED AS OF DATE:		20180122
DATE AS OF CHANGE:		20180122

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			GREY MICHAEL G
		CENTRAL INDEX KEY:			0001240122

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35921
		FILM NUMBER:		18540707

	MAIL ADDRESS:	
		STREET 1:		C/O SGX PHARMACEUTICALS, INC.
		STREET 2:		10505 ROSELLE STREET
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Mirati Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001576263
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				462693615
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		9393 TOWNE CENTRE DRIVE
		STREET 2:		SUITE 200
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		858-332-3410

	MAIL ADDRESS:	
		STREET 1:		9393 TOWNE CENTRE DRIVE
		STREET 2:		SUITE 200
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>marketforms-40824.xml
<DESCRIPTION>PRIMARY DOCUMENT
<TEXT>
Document 1 - file: marketforms-40824.html

Document 1 - RAW XML: marketforms-40824.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24
<SEQUENCE>2
<FILENAME>poa.htm
<DESCRIPTION>POA DOCUMENT
<TEXT>
Document 2 - file: poa.htm

</DOCUMENT>
</SEC-DOCUMENT>